Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

This webinar will describe a scalable, end-to-end, digital pathway for the detection of atrial fibrillation in the community.

Speaker: Professor Chris Gale
BSc (Hons), MB;BS, Ph.D, MEd, MSc, FESC, FRCP

Chris Gale is Professor of Cardiovascular Medicine at the University of Leeds and Honorary Consultant Cardiologist at Leeds General Infirmary. He is a leading trialist and health services researcher with expertise in cardiovascular care and outcomes, holding major research awards from NIHR and the British Heart Foundation. He has published extensively in top journals, including JAMA and The Lancet, and serves as Clinical Lead for the UK nationwide heart attack register (MINAP). Chris is a Fellow of the Royal College of Physicians and the European Society of Cardiology, and Co-Chair of The Lancet Regional Health – Europe Commission on Inequalities in Cardiovascular Health.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:30 – 12:45 – Presentation by Prof Chris Gale

12:45 – 12:55 – Q&A and discussion

12:55 – 13:00 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!